相关实验视频
Updated: Jan 7, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
869
中国成年人肥胖护理:从证据到临床实践
Jing An1,2,3, Qingyi Jia1, Yan Huang4,5
1Department of Endocrinology and Metabolism, Laboratory of Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu 610041, China.
Precision clinical medicine
|December 25, 2025
概括
在2023年,超过5亿中国成年人面临超重或肥胖,这给医疗保健带来了压力. 政策变化和新技术提供了机会,但需要解决错误诊断和健康不平等等挑战,以获得有效的肥胖护理.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 医疗保健政策 医疗保健政策
背景情况:
- 在2023年,超过5亿中国成年人超重或肥胖.
- 肥胖及其并发症 (心血管,脏,代谢疾病) 给健康和经济带来了巨大的负担.
- 中国的"体重管理年"倡议标志着对全面肥胖管理的政策转变.
研究的目的:
- 分析中国肥胖护理的不断变化的格局.
- 识别政策变化和技术进步带来的机遇和挑战.
- 突出传统干预措施的作用和未来在打击肥胖大流行中的方向.
主要方法:
- 审查政策变化和肥胖护理的技术发展.
- 分析包括错误诊断,人口差异和健康不平等在内的挑战.
- 考虑传统的生活方式干预措施 (例如,江南饮食,太极拳).
主要成果:
- 政策转变刺激了肥胖治疗和预防的快速技术进步.
- 仍然存在重大挑战,包括诊断准确性,种族数据的相关性和利益相关方的合作.
- 传统的中国饮食和活动提供了文化相关的生活方式干预措施.
结论:
- 技术创新,特别是数字健康和新药,对于中国未来的肥胖护理至关重要.
- 应对诸如健康不平等等挑战,改善跨部门合作至关重要.
- 需要政策制定者和实践者的紧急,协调一致的努力来管理中国的肥胖危机.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
195
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
195
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
218
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
218
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
153
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
153
Chronic Pancreatitis II: Collaborative Care
284
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
284
Acute Coronary Syndrome IV: Interprofessional Care
197
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
197

